Showing results (111-120 of 660) with videos related to
Sort By:
Pageof 66
Nature Cancer|July 12, 2024
Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancerJavier Fernandez-Mateos, George D Cresswell, Nicholas Trahearn, et al.Nature Cancer|July 11, 2024
A first-in-class selective inhibitor of EGFR and PI3K offers a single-molecule approach to targeting adaptive resistanceChristopher E Whitehead, Elizabeth K Ziemke, Christy L Frankowski-McGregor, et al.Nature Cancer|July 3, 2024
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomicsDanh-Tai Hoang, Gal Dinstag, Eldad D Shulman, et al.Nature Cancer|March 26, 2024
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancersMaishara Muquith, Magdalena Espinoza, Andrew Elliott, et al.Nature Cancer|August 28, 2023
Tumor-specific cholinergic CD4+ T lymphocytes guide immunosurveillance of hepatocellular carcinomaChunxing Zheng, Bryan E Snow, Andrew J Elia, et al.Nature Cancer|August 31, 2023
Myeloid-specific KDM6B inhibition sensitizes glioblastoma to PD1 blockadeSangeeta Goswami, Deblina Raychaudhuri, Pratishtha Singh, et al.Nature Cancer|January 10, 2024
Autotaxin-lysolipid signaling suppresses a CCL11-eosinophil axis to promote pancreatic cancer progressionSohinee Bhattacharyya, Chet Oon, Luis Diaz, et al.Nature Cancer|January 3, 2024
Presence of onco-fetal neighborhoods in hepatocellular carcinoma is associated with relapse and response to immunotherapyZiyi Li, Rhea Pai, Saurabh Gupta, et al.Nature Cancer|January 22, 2024
The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patientsArsen Osipov, Ognjen Nikolic, Arkadiusz Gertych, et al.Nature Cancer|February 15, 2024
Clinical and translational attributes of immune-related adverse eventsKarijn P M Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.Pageof 66